Tamoxifen Concept

subject area of

• neu/erbB-2 Overexpression and Response to Hormonal Therapy in Premenopausal Women in the Adjuvant Breast Cancer Setting: Will It Play in Peoria? Part II  Journal Articles
• A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer  Journal Articles
• A Trial of Two Questions  Journal Articles
• A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis  Journal Articles
• A novel synthetic C-1 analogue of 7-deoxypancratistatin induces apoptosis in p53 positive and negative human colorectal cancer cells by targeting the mitochondria: enhancement of activity by tamoxifen  Journal Articles
• A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada—Clinical Trials Group Trial, MA.12)  Journal Articles
• A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.  Journal Articles
• A role of SIPL1/SHARPIN in promoting resistance to hormone therapy in breast cancer  Journal Articles
• Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer a phase I/II study  Journal Articles
• Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial  Journal Articles
• American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002  Journal Articles
• An Integrated Approach to Male-Factor Subfertility: Bridging the Gap Between Fertility Specialists Trained in Urology and Gynaecology  Journal Articles
• An aromatase inhibitor and tamoxifen decrease plasma levels of o,p′-DDT and its metabolites in Nile tilapia (Oreochromis niloticus)  Journal Articles
• Application of Breast Cancer Risk Prediction Models in Clinical Practice  Journal Articles
• Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review  Journal Articles
• Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials  Journal Articles
• Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials  Journal Articles
• Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women  Journal Articles
• Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer  Journal Articles
• Asymptomatic Atypical Hyperplasia and Endometriosis Following Treatment with Tamoxifen: A Case Report and Review of the Literature  Journal Articles
• Asymptomatic Endometrial Thickening  Journal Articles
• Benefit From Exemestane As Extended Adjuvant Therapy After 5 Years of Adjuvant Tamoxifen: Intention-to-Treat Analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 Trial  Journal Articles
• Breast Cancer Consensus Meetings: Vive la Difference?  Journal Articles
• Canada's Population Health Model (POHEM)  Journal Articles
• Chemoprevention of breast cancer. A joint guideline from the Canadian Task Force on Preventive Health Care and the Canadian Breast Cancer Initiative's Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.  Journal Articles
• Chemoprevention: Drug pricing and mortality  Journal Articles
• Chemotherapy for older women with node-positive breast cancer.  Journal Articles
• Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer  Journal Articles
• Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer  Journal Articles
• Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update).  Journal Articles
• Clomiphene or tamoxifen for idiopathic oligo/asthenospermia  Journal Articles
• Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation Carriers  Journal Articles
• Developmental changes in the gonadotropin releasing hormone neuron of the female rabbit: effects of tamoxifen citrate and pregnant mare serum gonadotropin  Journal Articles
• Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers  Journal Articles
• Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17  Journal Articles
• Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93  Journal Articles
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials  Journal Articles
• Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17  Journal Articles
• Endometrial Evaluation with Transvaginal US and Hysterosonography in Asymptomatic Postmenopausal Women with Breast Cancer Receiving Tamoxifen  Journal Articles
• Endometrial cancer. Prevention, detection, management, and follow up.  Journal Articles
• European oncologists' preferences for the management of breast cancer: case presentations and expert commentary  Journal Articles
• Factors Promoting Tamoxifen Resistance in Breast Cancer via Stimulating Breast Cancer Stem Cell Expansion  Journal Articles
• First do no harm: extending the debate on the provision of preventive tamoxifen  Journal Articles
• Functional characterization of estrogen receptor subtypes, ERα and ERβ, mediating vitellogenin production in the liver of rainbow trout  Journal Articles
• Give us clear, not convoluted, clinical practice guidelines.  Journal Articles
• Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole  Journal Articles
• Incidence of endometrial cancer in BRCA mutation carriers.  Journal Articles
• International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers  Journal Articles
• Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues  Journal Articles
• Managing patients on endocrine therapy: Focus on quality-of-life issues  Conferences
• Modulatory effects of estrogen in two murine models of experimental colitis  Journal Articles
• OESTROGEN MODULATORS AND CLEAR CELL CARCINOMA OF VAGINA  Journal Articles
• Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the Breast  Journal Articles
• Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx  Journal Articles
• Polychemotherapy for early breast cancer: an overview of the randomised trials  Journal Articles
• Polycomb complex protein BMI1 confers resistance to tamoxifen in estrogen receptor positive breast cancer  Journal Articles
• Preferences of Women Evaluating Risks of Tamoxifen (POWER) study of preferences for tamoxifen for breast cancer risk reduction  Journal Articles
• Preparation and Evaluation of Carborane Analogues of Tamoxifen  Journal Articles
• Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model  Journal Articles
• Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial  Journal Articles
• Protein Kinase C and Oxidative Stress in an Animal Model of Mania  Journal Articles
• Pulmonary lymphangiomyomatosis complicating pregnancy. A case report.  Journal Articles
• Radiation Therapy and Tamoxifen: Concurrent or Sequential? That Is the Question  Journal Articles
• Randomized Trial of Tamoxifen Versus Combined Tamoxifen and Octreotide LAR Therapy in the Adjuvant Treatment of Early-Stage Breast Cancer in Postmenopausal Women: NCIC CTG MA.14  Journal Articles
• Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.  Journal Articles
• Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma  Journal Articles
• Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group.  Journal Articles
• Recruitment strategies for minority participation: challenges and cost lessons from the POWER interview.  Journal Articles
• Reduction in Tamoxifen Metabolites Endoxifen and N-desmethyltamoxifen With Chronic Administration of Low Dose Cannabidiol: A CYP3A4 and CYP2D6 Drug Interaction  Journal Articles
• Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials  Journal Articles
• Sensitization of human melanoma cells by tamoxifen to apoptosis induction by pancratistatin, a nongenotoxic natural compound  Journal Articles
• Synergy of pancratistatin and tamoxifen on breast cancer cells in inducing apoptosis by targeting mitochondria  Journal Articles
• Synthesis of Boroxifen, A Nido-Carborane Analogue of Tamoxifen  Journal Articles
• TAMOXIFEN PROPHYLAXIS  Journal Articles
• Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015  Journal Articles
• Tamoxifen Attenuates the Effects of Exogenous Glucocorticoid on Bone Formation and Growth in Piglets*  Journal Articles
• Tamoxifen Derivatives for Delivery of the Antitumoral (DACH)Pt Group: Selective Synthesis by McMurry Coupling, and Biochemical Behaviour  Journal Articles
• Tamoxifen May Be an Effective Adjuvant Treatment for BRCA1-Related Breast Cancer Irrespective of Estrogen Receptor Status  Journal Articles
• Tamoxifen and cancer of the endometrium.  Journal Articles
• Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update  Journal Articles
• Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation  Journal Articles
• Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania  Journal Articles
• Tamoxifen flare — an unusual case of hypercalcaemia and transient rapidly progressive pancytopenia  Journal Articles
• Tamoxifen for Breast Cancer Risk Reduction  Journal Articles
• Tamoxifen for early breast cancer: an overview of the randomised trials  Journal Articles
• The Thrombogenic Effect of Anticancer Drug Therapy in Women with Stage II Breast Cancer  Journal Articles
• The Use of Stereotactic Excisional Biopsy in the Management of Invasive Breast Cancer  Journal Articles
• The association between tamoxifen and the development of hepatocellular carcinoma: case report and literature review.  Journal Articles
• The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation  Journal Articles
• The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures  Journal Articles
• The evidence for tamoxifen and chemotherapy as treatment for metastatic melanoma  Journal Articles
• Thromboembolic risk of tamoxifen in patients with stage II breast cancer.  Journal Articles
• Thrombosis of the Cerebral Veins and Sinuses  Journal Articles
• Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor  Journal Articles
• Towards optimal endocrine therapy for hormone-sensitive breast cancer: Initial versus sequential adjuvant aromatase inhibition  Journal Articles
• Transvaginal US and Hysterosonography in Postmenopausal Women with Breast Cancer Receiving Tamoxifen: Correlation with Hysteroscopy and Pathologic Study  Journal Articles
• Ultrasonographic Assessment of Endometrial Thickness: A Review  Journal Articles
• Utility of in vitro test methods to assess the activity of xenoestrogens in fish  Journal Articles
• Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor–Positive Postmenopausal Breast Cancer Patients in the TEAM Trial  Journal Articles
• Venous Thromboembolism in Malignancy and Malignancy in Venous Thromboembolism  Journal Articles
• WITHDRAWN: Clomiphene or tamoxifen for idiopathic oligo/asthenospermia.  Journal Articles
• o,p′-DDT induction of vitellogenesis and its inhibition by tamoxifen in Nile tilapia (Oreochromis niloticus)  Journal Articles